S
Sonomotion
Developing Innovations in Non-Invasive Kidney Stone Treatment
About Sonomotion
SonoMotion is a medical device company that has developed a non-invasive platform for the treatment of kidney stones. The company's product line includes the Break Wave™ system, which uses lithotripsy to fragment kidney stones, and the Stone Clear device, which has received FDA de novo clearance for the non-invasive treatment of post-lithotripsy kidney stone fragments.
Read full description
The company's technology is designed to be used on fully awake patients in various clinical settings, which could potentially reduce the need for more invasive procedures and anesthesia. SonoMotion has been actively engaged in clinical trials to validate its technology, having completed enrollment in a pivotal trial for its Break Wave™ system. The company has also secured funding through grants, including a $2.2 million Fastrack NIH SBIR grant, to support the development of its products.
The target market for SonoMotion's products includes hospitals, urology clinics, and other healthcare facilities that treat patients with kidney stones. The business model is likely based on the sale of its medical devices to these healthcare providers. By offering a non-invasive solution, SonoMotion aims to improve patient outcomes and reduce healthcare costs associated with kidney stone treatment.
At a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- San Mateo, United States
- Employees
- 13
- Open positions
- None listed
- Dealroom signal
- 76.4/100
- Industry
- Health
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Innovation Management, Biotechnology, Ultrasound, Non-Invasive medical devices and treatments, Spinout, Biotech and Pharma, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES C✓Equity / VC | Nov 2022 | $12M | $50M | Lyndon Rive · Advanced MedTech Holdings | ↗ |
| SERIES CEquity / VC | Apr 2022 | $12M | $50M | Advanced MedTech Holdings | ↗ |
Growth signals
Latest recorded traffic for Sonomotion is 2.9K monthly website visits, up 141.7% over the last three months. Sonomotion's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- BIBioventures Investors
Series B and later2 investors entered at this stage
Advanced MedTech Holdings
Lyndon Rive
Other known investors3 additional known investors
The University of British Columbia
University of Washington
Small Business Innovation Research
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Sonomotion on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Sonomotion’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.